Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma

by Bryan Gardam, Bryan Gardam, Tessa Gargett, Tessa Gargett, Tessa Gargett, Michael P. Brown, Michael P. Brown, Michael P. Brown, Lisa M. Ebert, Lisa M. Ebert, Lisa M. Ebert
Published 2023-10-01

Clinical chimeric antigen receptor‐T cell therapy: a new and promising treatment modality for glioblastoma

by Michael P Brown, Lisa M Ebert, Tessa Gargett
Published 2019-01-01

Clinical chimeric antigen receptor T‐cell therapy: a new and promising treatment modality for glioblastoma

by Michael P Brown, Lisa M Ebert, Tessa Gargett
Published 2021-01-01

Effects of Chemotherapy Agents on Circulating Leukocyte Populations: Potential Implications for the Success of CAR-T Cell Therapies

by Nga T. H. Truong, Tessa Gargett, Michael P. Brown, Lisa M. Ebert
Published 2021-05-01

Effective γδ T‐cell clinical therapies: current limitations and future perspectives for cancer immunotherapy

by Isabella A Revesz, Paul Joyce, Lisa M Ebert, Clive A Prestidge
Published 2024-01-01

The Role of Cytokines and Chemokines in Shaping the Immune Microenvironment of Glioblastoma: Implications for Immunotherapy

by Erica C. F. Yeo, Michael P. Brown, Tessa Gargett, Lisa M. Ebert
Published 2021-03-01

Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapy

by Chad Pickering, Paul Aiyetan, Gege Xu, Alan Mitchell, Rachel Rice, Yana G. Najjar, Joseph Markowitz, Joseph Markowitz, Lisa M. Ebert, Lisa M. Ebert, Lisa M. Ebert, Michael P. Brown, Michael P. Brown, Michael P. Brown, Gonzalo Tapia-Rico, Dennie Frederick, Xin Cong, Daniel Serie, Klaus Lindpaintner, Flavio Schwarz, Genevieve M. Boland
Published 2023-06-01

A cancer vaccine induces expansion of NY-ESO-1-specific regulatory T cells in patients with advanced melanoma.

by Lisa M Ebert, Sarah E MacRaild, Damien Zanker, Ian D Davis, Jonathan Cebon, Weisan Chen
Published 2012-01-01

Characterising Distinct Migratory Profiles of Infiltrating T-Cell Subsets in Human Glioblastoma

by Paris M. Kollis, Paris M. Kollis, Lisa M. Ebert, Lisa M. Ebert, Lisa M. Ebert, John Toubia, Cameron R. Bastow, Rebecca J. Ormsby, Santosh I. Poonnoose, Santosh I. Poonnoose, Sakthi Lenin, Melinda N. Tea, Stuart M. Pitson, Stuart M. Pitson, Guillermo A. Gomez, Michael P. Brown, Michael P. Brown, Michael P. Brown, Tessa Gargett, Tessa Gargett, Tessa Gargett
Published 2022-04-01

Desmoglein-2 as a cancer modulator: friend or foe?

by Kay K. Myo Min, Charlie B. Ffrench, Barbara J. McClure, Barbara J. McClure, Michael Ortiz, Emma L. Dorward, Michael S. Samuel, Michael S. Samuel, Michael S. Samuel, Lisa M. Ebert, Lisa M. Ebert, Mỹ G. Mahoney, Claudine S. Bonder, Claudine S. Bonder
Published 2023-12-01

CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix

by Carmela Martini, Mark DeNichilo, Danielle P. King, Michaelia P. Cockshell, Brenton Ebert, Brian Dale, Lisa M. Ebert, Anthony Woods, Claudine S. Bonder
Published 2021-07-01

Interleukin-3 greatly expands non-adherent endothelial forming cells with pro-angiogenic properties

by Lachlan M. Moldenhauer, Michaelia P. Cockshell, Lachlan Frost, Kate A. Parham, Denis Tvorogov, Lih Y. Tan, Lisa M. Ebert, Katie Tooley, Stephen Worthley, Angel F. Lopez, Claudine S. Bonder
Published 2015-05-01

Vasculogenic mimicry structures in melanoma support the recruitment of monocytes

by Lih Y. Tan, Michaelia P. Cockshell, Eli Moore, Kay K. Myo Min, Michael Ortiz, M. Zahied Johan, Brenton Ebert, Andrew Ruszkiewicz, Michael P. Brown, Lisa M. Ebert, Claudine S. Bonder
Published 2022-12-01

Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers

by Gonzalo Tapia Rico, Michael P Brown, Andrew Ruszkiewicz, Amy Johnson, Tessa Gargett, Lisa M Ebert, Nga T H Truong, Wenbo Yu, Erica C F Yeo, Nicole L Wittwer, Bryan Gardam, Jesikah Logan, Purany Sivaloganathan, Maria Collis
Published 2024-05-01

Desmoglein‐2 expression is an independent predictor of poor prognosis patients with multiple myeloma

by Lisa M. Ebert, Kate Vandyke, M. Zahied Johan, Mark DeNichilo, Lih Y. Tan, Kay K. Myo Min, Benjamin M. Weimann, Brenton W. Ebert, Stuart M. Pitson, Andrew C. W. Zannettino, Craig T. Wallington‐Beddoe, Claudine S. Bonder
Published 2022-03-01

A Drug Screening Pipeline Using 2D and 3D Patient-Derived In Vitro Models for Pre-Clinical Analysis of Therapy Response in Glioblastoma

by Sakthi Lenin, Elise Ponthier, Kaitlin G. Scheer, Erica C. F. Yeo, Melinda N. Tea, Lisa M. Ebert, Mariana Oksdath Mansilla, Santosh Poonnoose, Ulrich Baumgartner, Bryan W. Day, Rebecca J. Ormsby, Stuart M. Pitson, Guillermo A. Gomez
Published 2021-04-01

43 Harnessing the power of glycoproteomics: a cutting-edge approach for predicting treatment efficacy in metastatic melanoma with immune checkpoint inhibitors

by Joseph Markowitz, Yana G Najjar, Michael P Brown, Dennie Frederick, Genevieve M Boland, Klaus Lindpaintner, Gege Xu, Rachel Rice, Daniel Serie, Lisa M Ebert, Alan Mitchell, Xin Cong, Gonzalo Tapia-Rico, Chad Pickering, Paul Aiyetan, Ranjan Bhadra, Chirag Dhar, Flavio Schwarz
Published 2023-11-01

GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma

by Jake Nowicki, Michael P Brown, Tessa Gargett, Lisa M Ebert, Nga T H Truong, Paris M Kollis, Kristyna Sedivakova, Wenbo Yu, Erica C F Yeo, Nicole L Wittwer, Briony L Gliddon, Melinda N Tea, Rebecca Ormsby, Santosh Poonnoose, Orazio Vittorio, David S Ziegler, Stuart M Pitson
Published 2022-09-01

3D-printed microplate inserts for long term high-resolution imaging of live brain organoids

by Mariana Oksdath Mansilla, Camilo Salazar-Hernandez, Sally L. Perrin, Kaitlin G. Scheer, Gökhan Cildir, John Toubia, Kristyna Sedivakova, Melinda N. Tea, Sakthi Lenin, Elise Ponthier, Erica C. F. Yeo, Vinay Tergaonkar, Santosh Poonnoose, Rebecca J. Ormsby, Stuart M. Pitson, Michael P. Brown, Lisa M. Ebert, Guillermo A. Gomez
Published 2021-04-01

Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy

by Lisa M Ebert, Wenbo Yu, Tessa Gargett, John Toubia, Paris M Kollis, Melinda N Tea, Brenton W Ebert, Cedric Bardy, Mark van den Hurk, Claudine S Bonder, Jim Manavis, Kathleen S Ensbey, Mariana Oksdath Mansilla, Kaitlin G Scheer, Sally L Perrin, Rebecca J Ormsby, Santosh Poonnoose, Barbara Koszyca, Stuart M Pitson, Bryan W Day, Guillermo A Gomez, Michael P Brown
Published 2020-01-01